PMC4051820_01
Images of the right eye at baseline (T0) optical coherence tomography (OCT), central macular thickness (CMT) 551, 3 weeks after starting treatment CMT 401, 6 months after starting treatment (T2) CMT 376.
oed-6-2014-021f1.jpg
PMC4051820_01_oed-6-2014-021f1.jpg
f1-oed-6-2014-021
This resulted in reduction of macular edema in 7 days as documented by OCT (Fig. 1).
PMC4051820_02
Images of the left eye at baseline (T0) optical coherence tomography (OCT), central macular thickness (CMT) 463, 3 weeks after starting treatment CMT 330, 6 months after .starting treatment (T2) CMT 322.
oed-6-2014-021f2.jpg
PMC4051820_02_oed-6-2014-021f2.jpg
f2-oed-6-2014-021
Topical therapy began using dorzolamide three times daily in each eye, with considerable improvement of the edema (higher in OD than in OS), which was detectable with OCT around the 15th day of treatment (Fig. 2).
PMC4051820_03